SIX6 Human Recombinant (PRO-1253) is a 269-amino-acid polypeptide (1-246 a.a.) with a 23-amino-acid N-terminal His-tag, produced in Escherichia coli. Key properties include:
SIX6, a member of the SIX/Sine oculis homeobox family, regulates:
Eye Development: Expressed in optic vesicles and retina precursors; activates retina-specific genes (ALDH1A3, VSX2, LHX2) .
Forebrain Patterning: Critical for hypothalamic and pituitary development .
Progenitor Maintenance: Interacts with PAX6 and OTX2 to sustain retinal ganglion cell precursors .
Binds to DNA via its homeodomain, acting as a transcriptional repressor in collaboration with EYA2 and DACH1 .
Hypoxia, Wnt, and SHH signaling enhance SIX6+ organoid formation in human pluripotent stem cell models .
Tissue-specific expression (Human Protein Atlas ):
Tissue | Expression Level | Functional Relevance |
---|---|---|
Retina | High | Photoreceptor development, optic nerve patterning |
Hypothalamus | Moderate | Neuroendocrine regulation |
Pituitary Gland | Moderate | Hormone secretion pathways |
Midbrain/Hindbrain | Low | Limited to early developmental stages |
Microphthalmia/Cataracts: Loss-of-function mutations (e.g., c.547delG) disrupt optic vesicle morphogenesis .
Pituitary Anomalies: Hemizygous deletions at 14q22.3-q23 correlate with SIX6 haploinsufficiency .
CRISPR-generated SIX6-GFP reporter lines enable real-time tracking of retinal differentiation. Key findings:
SIX6+ organoids show 100-fold higher SIX6 expression versus controls (p < 10⁻⁶) .
Co-expression with POU4F2 (retinal ganglion cell marker) confirms retinogenesis fidelity .
Pathogenic variants in SIX6 are linked to:
SIX6 plays a crucial role in the differentiation and survival of retinal ganglion cells during human development . Current research indicates that SIX6 functions as a transcription factor that regulates neural progenitor proliferation in the developing retina and optic nerve. The protein functions within a network of transcription factors essential for proper eye formation and maintenance. Experimental approaches using CRISPR-generated reporter systems have demonstrated that SIX6 expression is detectable in early optic vesicle formation, confirming its fundamental role in retinogenesis .
While both genes belong to the SIX family of homeodomain-containing transcription factors, they exhibit distinct tissue-specific expression patterns. SIX6 shows predominant expression in the developing retina, hypothalamus, and midbrain/hindbrain territories as demonstrated through reporter studies . SIX1, while also expressed in some neural tissues, has broader expression in non-neural tissues. This differential expression reflects their distinct developmental roles and explains why certain SIX6 variants primarily affect ocular tissues while having minimal impact on other systems.
The development of CRISPR-generated SIX6-GFP and POU4F2-tdTomato reporter systems has revolutionized the study of SIX6 expression patterns. These reporters provide reliable readouts for developing human retina, hypothalamus, and midbrain/hindbrain regions . For studying SIX6 in human development:
3D organoid systems - Human pluripotent stem cells grown in 3D can self-assemble into laminar organized retinas
Fluorescence reporter systems - SIX6-GFP allows visualization of gene expression in real-time
RNA sequencing - Enables transcriptional profiling of SIX6-expressing tissues
Environmental manipulation - Research has shown that hypoxic growth conditions enhance SIX6 expression and promote eye formation
Several SIX6 polymorphisms have been associated with increased glaucoma risk through genome-wide association studies. Particularly significant are:
Variant | Location | Association Strength | Functional Consequence |
---|---|---|---|
rs10483727 | SIX1 region | Significant across ethnicities | Unknown protein function effect |
rs33912345 (Asn141His) | SIX6 locus | Strong linkage with rs10483727 | Alters SIX6 protein function |
These variants appear to exert age-dependent effects on retinal nerve fiber layer (RNFL) thickness. Research has found that these genetic variants do not cause significant RNFL thinning in younger individuals but manifest their effects later in adult life . The molecular mechanisms likely involve altered transcriptional regulation of genes involved in retinal ganglion cell development and survival.
The age-dependent effects of SIX6 variants on RNFL thickness represent a fascinating research question. Studies comparing healthy young adults (mean age 20 years) with older cohorts (mean age 63 years) found that while younger individuals show no significant RNFL thinning with each copy of risk alleles, older individuals exhibited unexpected regional variations . The data suggests:
Older adults with SIX6 risk alleles show thicker RNFL in nasal sectors
Thinner RNFL was observed in temporal sectors with each copy of the risk allele
These patterns suggest that SIX6 variants may influence the normal aging process of retinal ganglion cells or interact with other age-dependent factors
The mechanisms behind this age-dependent manifestation are not fully understood but may involve cumulative stress, delayed neurodegeneration, or interactions with other age-related genetic or environmental factors.
Recent research has identified novel compound heterozygous variants in SIX6 causing optic disc dysplasia and macular abnormalities without coexisting cataract or microphthalmia . These findings expand our understanding of SIX6-related phenotypes. The compound heterozygous state, where different mutations are present on each allele, can produce phenotypes that are distinct from those seen in homozygous variants. This suggests that different functional domains of the SIX6 protein may be affected differently by various mutations, leading to diverse clinical presentations.
Notably, these SIX6-related optic disc abnormalities may be clinically indistinguishable from those seen in PAX2-related Papillo-renal syndrome, highlighting the importance of molecular genetic testing to establish accurate diagnosis .
CRISPR-generated reporter systems have emerged as powerful tools for visualizing SIX6 expression patterns in developing tissues. Based on recent research, optimization strategies include:
Dual reporter systems - The SIX6-GFP/POU4F2-tdTomato dual reporter line labels the entire developing retina and retinal ganglion cells, respectively, allowing simultaneous visualization of multiple cell populations
Environmental condition manipulation - Early hypoxic growth conditions enhance SIX6 expression and promote eye formation in reporter systems
Signaling pathway modulation - Sequential inhibition of Wnt and activation of sonic hedgehog signaling further enhances SIX6 expression in experimental models
Organoid selection strategies - Harvesting specific organoid populations (SIX6+/POU4F2-, SIX6-) allows identification and study of different brain regions including the hypothalamus and midbrain-hindbrain territories
These methodological refinements enable more precise study of SIX6 expression dynamics and functional relationships in developmental contexts.
RNA sequencing of SIX6-expressing tissues provides valuable insights into developmental processes. Recent studies demonstrate that:
SIX6+ optic vesicles show RNA expression profiles consistent with retinal identity, though ventral diencephalic markers are also present
Transcriptional profiling can reliably distinguish between developing human retina, hypothalamus, and midbrain/hindbrain organoids
Single-cell RNA sequencing allows identification of cell-type specific expression patterns within SIX6+ tissues
Temporal transcriptomic analysis reveals dynamic changes in gene expression during development of SIX6-expressing structures
For meaningful analysis, researchers should combine bulk and single-cell approaches, incorporate time-course designs, and validate findings through reporter visualization or in situ hybridization techniques.
Distinguishing SIX6-related optic disc dysplasia from other similar conditions presents a significant diagnostic challenge. Recent research indicates that SIX6-related dysplastic optic discs may be clinically indistinguishable from those seen in PAX2-related Papillo-renal syndrome . For accurate differentiation:
Comprehensive genetic testing - Whole Exome Sequencing (WES) can reveal compound heterozygous or homozygous variants in SIX6
Cascade family screening - Testing parents for heterozygous status helps confirm pathogenicity of variants
Careful optic disc evaluation - Detection of subtle disc dysplasia is critical in differentiating this rare entity from more common causes of cone dystrophies
Extended phenotyping - Assessment for non-ocular abnormalities associated with alternative diagnoses (e.g., renal abnormalities in PAX2-related conditions)
This multi-faceted approach enhances diagnostic accuracy and allows appropriate genetic counseling.
Novel SIX6 variants absent from reference populations (such as 1000G, ExAC, or ethnicity-specific databases) require careful evaluation to determine pathogenicity . These rare variants may represent:
Population-specific genetic variation not yet captured in existing databases
Recent de novo mutations with limited population spread
Highly penetrant pathogenic variants subject to negative selection
For variants not found in reference populations, researchers should conduct comprehensive functional studies to assess protein expression, DNA binding capacity, transcriptional regulation activity, and protein-protein interactions with known SIX6 partners. These experimental approaches provide critical evidence for variant classification and clinical interpretation.
Identifying the complete repertoire of SIX6 transcriptional targets represents a critical research frontier. By characterizing these downstream genes, researchers can:
Identify key pathways amenable to therapeutic intervention
Develop more precise disease models focusing on specific downstream effectors
Design targeted therapies that bypass SIX6 dysfunction by directly modulating critical target genes
Research approaches should combine chromatin immunoprecipitation sequencing (ChIP-seq) with transcriptional profiling of tissues with modified SIX6 expression to build comprehensive gene regulatory networks. This integrative approach will reveal the most promising therapeutic targets within the SIX6 pathway.
The age-dependent effects of SIX6 variants highlight the importance of understanding temporal dynamics in SIX6 function. Current research indicates that SIX6 variants exert their influence later in adult life , suggesting complex temporal regulation. To investigate this phenomenon:
Longitudinal imaging studies - Track retinal changes in individuals with SIX6 variants across different age groups
Inducible gene expression systems - Activate or suppress SIX6 at different developmental timepoints
Age-stratified transcriptomic analysis - Compare gene expression profiles between young and old individuals with SIX6 variants
Epigenetic profiling - Examine age-dependent changes in chromatin structure and DNA methylation at SIX6 regulatory regions
These approaches will help elucidate how SIX6 function changes throughout the lifespan and may reveal critical windows for therapeutic intervention.
The SIX6 gene is located on chromosome 14 and is part of a cluster of related genes. The protein encoded by this gene is similar to the Drosophila ‘sine oculis’ gene product . SIX6 Human Recombinant is produced in Escherichia coli (E. coli) and is a single, non-glycosylated polypeptide chain containing 269 amino acids, with a molecular mass of 30.1 kDa . The recombinant protein is fused to a 23 amino acid His-tag at the N-terminus and is purified using proprietary chromatographic techniques .
SIX6 plays a significant role in the development of the retina, hypothalamus, and pituitary regions. It provides essential instructions for the formation of these structures during embryonic development . Defects in the SIX6 gene are associated with microphthalmia isolated with cataract type 2, a condition characterized by abnormally small eyes and cataracts .
The recombinant SIX6 protein is expressed in E. coli and is purified to a high degree of purity, greater than 90% as determined by SDS-PAGE . The protein is formulated in a sterile, filtered colorless solution containing 20mM Tris-HCl buffer (pH 8.0), 0.2M NaCl, 40% glycerol, 5mM DTT, and 2mM EDTA .
The SIX6 recombinant protein is used in various research applications, including studies on eye development, forebrain formation, and related genetic disorders. It is also valuable in understanding the molecular mechanisms underlying these developmental processes.